Mechanism of mupirocin transport into sensitive and resistant bacteria.

Antimicrobial Agents and Chemotherapy
J O CapobiancoR C Goldman

Abstract

Pseudomonic acid A (mupirocin) blocks protein synthesis in bacteria by inhibition of bacterial isoleucyl-tRNA synthetase. [16, 17-3H]mupirocin, isolated from a methionine auxotroph of Pseudomonas fluorescens, was used to study transport of this antibiotic into sensitive and resistant strains of Bacillus subtilis, Staphylococcus aureus, and Escherichia coli. The transport of mupirocin into sensitive bacteria was energy independent and temperature dependent (decreased uptake at lower temperatures), indicating non-carrier-mediated passive diffusion. Uptake was also saturable with time or increasing antibiotic concentration. The saturable intracellular binding site, most likely the target isoleucyl-tRNA synthetase as determined by the amount of bound mupirocin (2,700 to 3,100 molecules per cell), caused concentration of the antibiotic within the cell. E. coli transformed with a plasmid containing ileS overproduced the target enzyme and demonstrated greater accumulation of mupirocin than a strain containing a control plasmid. The concentrations needed to half saturate (Kd) these binding sites in B. subtilis and S. aureus were 35 and 7 nM, respectively. In gram-positive organisms trained for mupirocin resistance, uptake was not satur...Continue Reading

References

Jan 1, 1977·Journal of the Chemical Society. Perkin Transactions 1·E B Chain, G Mellows
Jan 1, 1977·Journal of the Chemical Society. Perkin Transactions 1·T C FelineL Phillips
Jan 1, 1979·Methods in Enzymology·W W Cleland
Jun 1, 1987·Journal of Bacteriology·C L Harris
Apr 1, 1985·Antimicrobial Agents and Chemotherapy·R SutherlandA R White
May 1, 1985·The Journal of Antimicrobial Chemotherapy·M W Casewell, R L Hill
Jul 16, 1973·European Journal of Biochemistry·A DurekovićM R Kula
Sep 1, 1974·Journal of Bacteriology·F C NeidhardtD F Smith
Jan 1, 1969·Journal of Bacteriology·D H Calhoun, T W Feary
Oct 1, 1980·The Biochemical Journal·J Hughes, G Mellows
Jul 2, 1962·Biochimica Et Biophysica Acta·E C LINS E JORGENSEN

❮ Previous
Next ❯

Citations

Jun 1, 1993·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·W Witte, I Klare
Dec 1, 1989·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·B Cookson
May 1, 1989·Diagnostic Microbiology and Infectious Disease·R N Jones, A L Barry
Jun 13, 1998·Burns : Journal of the International Society for Burn Injuries·N Cook
Jun 1, 1997·International Journal of Antimicrobial Agents·F J Schmitz, M E Jones
Jan 22, 2003·Seminars in Dialysis·Jeffrey S Berns
Mar 24, 2011·Future Medicinal Chemistry·Robert C Goldman
Feb 13, 2002·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Miguel Pérez-FontánFrancisco Valdés
May 18, 2012·Dermatologic Therapy·Susan Y ChonStephen K Tyring
Sep 1, 1991·The Journal of Hospital Infection·B Slocombe, C Perry
Oct 1, 1993·Burns : Journal of the International Society for Burn Injuries·M J Vizcaino-AlcaideJ Rey-Calero
Jan 31, 2009·American Journal of Rhinology·Tong LePeter-John Wormald
Aug 30, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Paweł KwiatkowskiŁukasz Łopusiewicz
Apr 3, 2002·The Journal of Biological Chemistry·Joseph Austin, Eric A First
Apr 4, 1998·Antimicrobial Agents and Chemotherapy·J O CapobiancoP A Lartey
Aug 13, 2021·RSC Chemical Biology·Dmitrii Y TravinSvetlana Dubiley

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Related Papers

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
B D Cookson
The Journal of Antimicrobial Chemotherapy
G E Smith, C T Kennedy
Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
M ArvanitidouA Tsakris
© 2022 Meta ULC. All rights reserved